What medications are used to treat Helicobacter pylori infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

H. Pylori Treatment Medications

For treatment-naive H. pylori infection, bismuth quadruple therapy (bismuth, metronidazole, tetracycline, and PPI) for 14 days is the preferred first-line regimen when antibiotic susceptibility is unknown. 1

First-Line Treatment Options

The 2024 ACG guidelines provide three primary first-line regimens based on the most recent evidence and rising antibiotic resistance patterns (now exceeding 30% for clarithromycin, levofloxacin, and metronidazole in North America):

Preferred First-Line Regimen

Bismuth Quadruple Therapy (14 days):

  • Bismuth subsalicylate ~300mg four times daily
  • Metronidazole 500mg three to four times daily
  • Tetracycline 500mg four times daily
  • PPI (standard dose) twice daily

This regimen is preferred because it maintains effectiveness even in areas with high dual resistance to clarithromycin and metronidazole 2, 3, 1. The bismuth component helps overcome metronidazole resistance that may exist in vitro 3.

Alternative First-Line Options (When Bismuth Unavailable or Contraindicated)

Rifabutin Triple Therapy (14 days):

  • Rifabutin 150mg twice daily or 300mg once daily
  • Amoxicillin 1000mg twice daily
  • PPI (standard dose) twice daily

This is particularly suitable for patients without penicillin allergy and is reasonable to prescribe without prior sensitivity testing since rifabutin and amoxicillin resistance remain rare 2, 1.

Potassium-Competitive Acid Blocker (P-CAB) Dual Therapy (14 days):

  • P-CAB with amoxicillin
  • This represents one of the three newly approved options since the 2017 guidelines 4, 1

Non-Preferred First-Line Option

Concomitant Therapy (14 days):

  • Clarithromycin 500mg twice daily
  • Amoxicillin 1000mg twice daily
  • Metronidazole 500mg twice daily
  • PPI (standard dose) twice daily

This is appropriate only in areas where bismuth is unavailable AND clarithromycin resistance is documented to be low 3. Given current resistance patterns in North America, this should generally be avoided as empiric therapy 1.

Important Caveat on Traditional Triple Therapy

Clarithromycin-based triple therapy (PPI + clarithromycin + amoxicillin) should be avoided as first-line empiric treatment due to declining eradication rates (now 70-85%) driven by increasing clarithromycin resistance 5, 1. This regimen should only be used if antibiotic susceptibility confirms clarithromycin sensitivity.

Salvage Therapy for Treatment Failures

After First Treatment Failure

"Optimized" Bismuth Quadruple Therapy (14 days) is preferred for patients not previously treated with this regimen 2, 1. The optimization refers to ensuring full 14-day duration and proper dosing.

Rifabutin Triple Therapy (14 days) is the preferred alternative for patients who previously failed optimized bismuth quadruple therapy 1.

After Multiple Failures

Levofloxacin-based regimens should only be used with confirmed antibiotic susceptibility testing:

  • Levofloxacin 500mg once daily
  • Amoxicillin 1000mg twice daily
  • PPI (standard dose) twice daily
  • Duration: 10-14 days 2, 3

High-Dose Dual Therapy (14 days):

  • Amoxicillin 2-3g daily in 3-4 divided doses
  • High-dose PPI (double standard dose) twice daily 2

This represents an emerging option for refractory cases and is considered acceptable by all major guidelines as a salvage option 2, 3.

Critical Dosing Details

Standard PPI doses (taken 30 minutes before meals on empty stomach):

  • Pantoprazole 40mg
  • Lansoprazole 30mg
  • Omeprazole 20mg
  • Esomeprazole 20mg
  • Rabeprazole 20mg

High-dose PPI means double these standard doses 2.

Key Clinical Pitfalls

  1. Duration matters: All guidelines now recommend 14 days for first-line therapy to maximize eradication success 3, 1. The 7-day regimens previously used have inferior outcomes.

  2. Avoid clarithromycin and levofloxacin empirically: These should only be used when susceptibility is confirmed, given resistance rates exceeding 30% 1.

  3. Sequential and hybrid therapies are not recommended: Despite earlier enthusiasm, these non-bismuth quadruple variations are considered non-ideal options 3.

  4. Antibiotic susceptibility testing is increasingly important: For treatment-experienced patients, testing should guide salvage regimen selection rather than empiric retreatment 2, 1.

  5. Probiotics are unproven: Despite marketing claims, adjunctive probiotics have no established benefit for H. pylori eradication and should be considered experimental 2.

Related Questions

What is the recommended treatment regimen for Helicobacter pylori infection in an adult patient without drug allergies?
In a 53-year-old patient with epigastric pain and suspected Helicobacter pylori infection, what treatment regimen should I prescribe?
What Helicobacter pylori eradication regimens are available, what are their specific indications, and how long is each regimen administered?
What is the recommended diagnosis and management for persistent Helicobacter pylori infection after initial eradication therapy?
In a patient with persistent Helicobacter pylori infection confirmed 30 days after a 2‑week eradication course who continues to have epigastric discomfort and heartburn, should I wait another two weeks before starting second‑line therapy and then consider an upper endoscopy (esophagogastroduodenoscopy, EGD)?
My relative experienced hives after an intravenous iron infusion; is it safe for me to receive an iron infusion?
For a patient with type 2 diabetes, arterial hypertension, early hepatic steatosis, and a BMI of 26.5, which is the more appropriate therapy—tirzepatide (Mounjaro) or semaglutide (Wegovy)—considering off‑label use?
Does pembrolizumab (Keytruda) require nephrology clearance before starting immunotherapy, and what renal function criteria determine the need for such clearance?
Can dehydration cause an elevated serum lactate level in the absence of infection?
What is the most common location of a chalazion?
What is the latest clinical practice guideline for IgA vasculitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.